These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18089456)

  • 21. Siblings with glaucoma, mental retardation and short stature.
    AlKaissi A; Hammou A; Ghachem MB; Nacib MN; Chehida FB; Karoui H; Baraitser M
    Clin Dysmorphol; 2003 Jul; 12(3):191-4. PubMed ID: 14564159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
    Williams ME
    Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-world doxercalciferol treatment in SHPT CKD stage 3 and 4: an analysis of change in iPTH and accordance to KDOQI recommendations.
    Kumar N; Lindberg J; David K; Morris J; Menoyo J
    Am J Nephrol; 2009; 29(2):71-8. PubMed ID: 18689981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sagliker Syndrome in a Patient with Secondary Hyperparathyroidism and Chronic Renal Insufficiency: A Case Report.
    Shakeri S; Zarehparvar Moghadam S; Sadeghi R; Ayati N
    Asia Ocean J Nucl Med Biol; 2018; 6(2):167-170. PubMed ID: 29998151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surgical treatment of secondary hyperparathyroidism in chronic renal failure. Report of 57 cases].
    Sayad H; Jai SR; Ahazzam J; Lakhloufi A; Chihab F; Bouzidi A; Aghai R; Tarass F; Ramdani B; Hachim K; Benghanem NG; Zaid D
    Tunis Med; 2008 Feb; 86(2):140-3. PubMed ID: 18444530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Floating-Harbor syndrome: case report.
    Genc G; Sarac A; Erkek Atay N; Kulali F
    Minerva Pediatr; 2008 Apr; 60(2):249-51. PubMed ID: 18449141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical issues of PTH assays in CKD.
    Komaba H; Goto S; Fukagawa M
    Bone; 2009 Apr; 44(4):666-70. PubMed ID: 19159701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of severe metastatic calcification in hemodialysis patients.
    Yeh SM; Hwang SJ; Chen HC
    Hemodial Int; 2009 Apr; 13(2):163-7. PubMed ID: 19432688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sleep disturbances in children and adolescents with non-dialysis-dependent chronic kidney disease.
    Sinha R; Davis ID; Matsuda-Abedini M
    Arch Pediatr Adolesc Med; 2009 Sep; 163(9):850-5. PubMed ID: 19736340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypovitaminosis D in chronic kidney disease patients: prevalence and treatment.
    Cuppari L; Garcia-Lopes MG
    J Ren Nutr; 2009 Jan; 19(1):38-43. PubMed ID: 19121769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of antihypertensive treatment in patients with chronic kidney disease.
    Król E; Czarniak P; Rutkowski B
    J Ren Nutr; 2008 Jan; 18(1):134-9. PubMed ID: 18089460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of anemia among women with chronic kidney disease in United States outpatient settings.
    Rasu RS; Jayawant SS; Abercrombie M; Balkrishnan R
    Womens Health Issues; 2009; 19(3):211-9. PubMed ID: 19447325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic options for mineral metabolism disorders in dialysis patients: a case report].
    Cozzolino M; Pasho S; Missaglia E; Crovetto C; Fallabrino G; Brancaccio D
    G Ital Nefrol; 2008; 25(2):234-7. PubMed ID: 18350504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin D therapy for chronic kidney disease.
    Bhan I; Thadhani R
    Semin Nephrol; 2009 Jan; 29(1):85-93. PubMed ID: 19121478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.
    Cozzolino M; Brancaccio D
    Expert Opin Pharmacother; 2008 Apr; 9(6):947-54. PubMed ID: 18377338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of the face in Loeys-Dietz syndrome type II: longitudinal observations from infancy in seven cases.
    Adès LC
    Clin Dysmorphol; 2008 Oct; 17(4):243-8. PubMed ID: 18978651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
    McCullough PA; Li S; Jurkovitz CT; Stevens L; Collins AJ; Chen SC; Norris KC; McFarlane S; Johnson B; Shlipak MG; Obialo CI; Brown WW; Vassalotti J; Whaley-Connell AT; Brenner RM; Bakris GL;
    Am Heart J; 2008 Aug; 156(2):277-83. PubMed ID: 18657657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
    Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
    J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.